King Luther Capital Management Corp Reata Pharmaceuticals Inc Transaction History

King Luther Capital Management Corp

$23 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$20.71 - $36.5 $62,130 - $109,500	-3,000 Reduced 4.38%	65,534 $1.99 Million
Q1 2022 May 11, 2022	SELL	$24.12 - $39.6 $239,391 - $393,030	-9,925 Reduced 12.65%	68,534 $2.25 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $940,834 - $4.08 Million	-36,737 Reduced 31.89%	78,459 $2.07 Million
Q3 2021 Nov 10, 2021	BUY	$100.0 - $143.02 $332,500 - $475,541	3,325 Added 2.97%	115,196 $11.6 Million
Q2 2021 Aug 13, 2021	BUY	$78.27 - $151.29 $16,436 - $31,770	210 Added 0.19%	111,871 $15.8 Million
Q1 2021 May 12, 2021	BUY	$94.25 - $132.81 $1.2 Million - $1.69 Million	12,705 Added 12.84%	111,661 $11.1 Million
Q4 2020 Feb 10, 2021	BUY	$102.03 - $184.62 $1.28 Million - $2.32 Million	12,566 Added 14.55%	98,956 $12.2 Million
Q3 2020 Nov 12, 2020	BUY	$93.53 - $163.34 $396,941 - $693,214	4,244 Added 5.17%	86,390 $8.42 Million
Q2 2020 Aug 12, 2020	BUY	$126.3 - $176.56 $2.14 Million - $2.99 Million	16,925 Added 25.95%	82,146 $12.8 Million
Q4 2019 Feb 12, 2020	SELL	$74.57 - $217.92 $3.11 Million - $9.08 Million	-41,661 Reduced 38.98%	65,221 $13.3 Million
Q3 2019 Nov 12, 2019	BUY	$71.26 - $95.75 $522,834 - $702,517	7,337 Added 7.37%	106,882 $8.58 Million
Q2 2019 Aug 12, 2019	BUY	$77.72 - $94.35 $46,632 - $56,610	600 Added 0.61%	99,545 $9.39 Million
Q4 2018 Feb 12, 2019	BUY	$48.76 - $76.44 $264,718 - $414,992	5,429 Added 5.81%	98,945 $5.55 Million
Q2 2018 Aug 13, 2018	BUY	$19.94 - $40.96 $598,618 - $1.23 Million	30,021 Added 47.28%	93,516 $3.27 Million
Q1 2018 May 08, 2018	BUY	$20.0 - $30.19 $116,740 - $176,219	5,837 Added 10.12%	63,495 $1.3 Million
Q3 2017 Nov 13, 2017	BUY	$26.29 - $31.88 $1.52 Million - $1.84 Million	57,658	57,658 $1.79 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.

Account